Browsing by Subject "Phosphodiesterase Type 5 Inhibitor (PDE5)"

Now showing items 1-1 of 1

    • Efficacy and Tolerability of Lodenafil Carbonate for Oral Therapy in Erectile Dysfunction: A Phase II Clinical Trial 

      Glina, Sidney; Toscano, Iderpol; Gomatzky, Celso [UNIFESP]; Goes, Plinio Moreira de [UNIFESP]; Nardozza Junior, Archimedes; Claro, Joaquim Francisco de Almeida [UNIFESP]; Pagani, Eduardo (Wiley-Blackwell, 2009-02-01)
      Oral treatment with phosphodiesterase type 5 inhibitor (PDE5) is considered the first-line treatment for patients with erectile dysfunction (ED). Lodenafil carbonate (LC) is a novel PDE5.This is a phase II, prospective, ...